CHFR promoter hypermethylation was significantly related to the poor overall survival in patients with CRC, HR was 0.62 with 95% CI 0.44–0.88, z = 2.64, p = 0.008 (Figure 5). This evidence concerns the gene CHFR and colorectal carcinoma.